RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP
Clinical trial NCT03186482 · COMPLETED
Trial details
- NCT number
- NCT03186482
- Sponsor
- St. Stephens Clinical Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2018-01-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.